Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Hexagon Bio Logo
Hexagon Bio Growth Score
29
CB Rank
8159
Heat Score
64
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
Founded
obfuscation
PrivateSeries B Menlo Park, California, United States51-100 www.hexagonbio.com
Biotechnology
Health Care
Therapeutics
Overview

Hexagon Bio
Total Funding
obfuscation
Growth Score
29
Heat Score
64

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score29
-2 pts
in past quarter
Heat Score 64
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Hexagon Bio

CB Rank
8159
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
Founded
obfuscation
PrivateSeries B Menlo Park, California, United States51-100 www.hexagonbio.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Series B
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Hexagon Bio Inc.
Operating Status Active
Company Type For Profit
Founders  Maureen Hillenmeyer, Yi Tang
About the Company
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
Diversity Spotlight 
Women Founded
Women Led
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ADC Payload Discovery Platform
A platform that uses data science, genomics, and synthetic biology to identify novel small molecule cytotoxic payloads for antibody-drug conjugates (ADCs) from microbial genomes.
Proprietary Genomics Database of Secondary Metabolites
A database built from large-scale DNA sequencing of microbial genomes to identify novel secondary metabolites and their protein targets for drug discovery.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B
obfuscation
Series B - Hexagon Bio Logo
Series B - Hexagon Bio
6
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 2 Board Members and Advisors 4 Contacts 50

Employee Profiles

Board Members and Advisors

News

News and Press

News•Feb 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,362
2.79%
 in past month

IT Spend

$89.4KThis year, Hexagon Bio is projected to spend $89.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
COVID-19 App Logo
COVID-19 App
99
Mobile Workers Logo
Mobile Workers
96
Windows Operating System Logo
Windows Operating System
90

Active Website Tech Count

4Hexagon Bio is actively using 4 technologies for its website, according to BuiltWith. These include DNSSEC, SPF, and  CommonCrawl Top 5m.

Total IP

2The intellectual property of Hexagon Bio includes 2 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Hexagon Bio's headquarters? Hexagon Bio is located in Menlo Park, California, United States.Who invested in Hexagon Bio? Hexagon Bio has 10 investors including Two Sigma Ventures and  The Column Group.When was the last funding round for Hexagon Bio? Hexagon Bio closed its last funding round on
obfuscation
from a Series B round.Who are Hexagon Bio's competitors? Alternatives and possible competitors to Hexagon Bio may include Eli Lilly, Araris Biotech, and  Molecular Partners.How much funding has Hexagon Bio raised to date? Hexagon Bio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|